2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Needlestick Injuries: new trials by email Literature Review of Needlestick Injuries trials Research Report on Needlestick Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HCV Post-Exposure Prophylaxis for Health Care Workers Sofosbuvir/Velpatasvir Treatment for 14 days - Hepatitis C | Phase 4 | Withdrawn | Massachusetts General Hospital | 2019-08-13 | 2020-01-21 | |
| Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers Telaprevir - Viral Hepatitis C | Phase 4 | Withdrawn | Massachusetts General Hospital | 2013-04-01 | 2014-08-13 |
Hepatitis C (2)
Blood-Borne Infections (2) · Communicable Diseases (2) · Digestive System Diseases (2) · Flaviviridae Infections (2) · Hepatitis (2) · Hepatitis, Viral, Human (2) · Infections (2) · Liver Diseases (2) · RNA Virus Infections (2) · Virus Diseases (2) · Wounds and Injuries (2) · Wounds, Penetrating (2) · Wounds, Stab (2)
Sofosbuvir (1) · sofosbuvir-velpatasvir drug combination (1) · telaprevir (1)
Massachusetts General Hospital (2)
United States (2)
Raymond Chung, MD (1) · Raymond T. Chung, MD (1)